Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts.
暂无分享,去创建一个
D. de Ruysscher | S. Novello | E. Felip | F. de Marinis | F. Blackhall | C. Panje | B. Besse | P. Garrido | M. O'Brien | M. Reck | R. Califano | P. Putora | V. Westeel | M. Früh | F. Cappuzzo | L. Paz Ares